FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890935450> ?p ?o ?g. }

• W2890935450 abstract "Back to table of contents Previous article Next article Government NewsFull AccessSAMHSA Is Taking ‘New Directions,’ Says Agency LeaderLinda M. RichmondLinda M. RichmondSearch for more papers by this authorPublished Online:13 Sep 2018https://doi.org/10.1176/appi.pn.2018.9b10AbstractSAMHSA is sharpening its focus on evidence-based, community care for serious mental illness and combating the opioid epidemic.The Substance Abuse and Mental Health Services Administration (SAMHSA) is taking a new approach to addressing serious mental illness (SMI), with a renewed focus on evidence-based, collaborative care and reliance on community resource providers, such as peer support specialists, according to Elinore F. McCance-Katz, M.D., Ph.D., assistant secretary for mental health and substance use in the Department of Health and Human Services.SAMHSA’s “new directions” include providing evidence-based, community care for people with serious mental illness, prioritizing the training of health care practitioners, providing free national technical assistance, and funding innovative programs to combat the opioid epidemic, says Elinore F. McCance-Katz, M.D., Ph.D.David HathcoxMental illness, including substance use disorders, affects more than 64 million Americans every year. “Never in the history of this country has there been a time of greater need for attention to these issues,” McCance-Katz wrote last month in Psychiatric Services in Advance. “We are in the grip of an opioid crisis characterized by addiction and death such as we have never seen. Too often affecting our young people, the consequences of untreated mental illness and addiction have been tragic, frequently associated with violence and death.” Other initiatives by SAMHSA include prioritizing the training of health care practitioners to provide evidence-based treatment, working toward providing free national technical assistance and training, and funding innovative programs to combat the opioid epidemic, McCance-Katz wrote.The agency’s new approach to SMI will be supported by the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), a public-federal partnership aimed at improving services for adults and youth living with SMI. The agency will focus on mental health court programs, assisted outpatient treatment (known as AOT, or court-supervised community treatment), assertive community treatment teams, and expanding its successful certified community behavioral health clinics—now established in eight states—that provide integrated services as well as crisis care. As part of the effort to build a national system of free or low-cost practical training and technical assistance available to any organization or practitioner, SAMHSA created the national Clinical Support System for Serious Mental Illness (CSS-SMI) and chose APA as the grantee to implement the program. It will provide training, webinars, and classroom-style training on evidence-based approaches to serious mental illness, including pharmacotherapy, use of clozapine for treatment-resistant schizophrenia, use of long-acting antipsychotics, and ways to address metabolic syndrome.The agency is also planning to help expand suicide prevention programs. One of these programs is Zero Suicide, which trains health care professionals on how to ask about suicidality and make safety plans to get people into care. In 2016, more than 45,000 Americans died by suicide, a 30 percent increase over the past 15 years. The agency is continuing to fund innovative programs to address the epidemic of opioid abuse and will use its 2018 funding boost to expand efforts with a proven track record of success. These initiatives include drug courts, programs for pregnant and postpartum women with opioid use disorder, naloxone distribution and training, peer specialist training, and minority fellowship funding for physicians and psychologists working with patients with substance use disorder. SAMHSA will also, for the first time, provide funding to educate physicians, physician assistants, and nurse practitioners so they can provide office-based buprenorphine treatment.“These are important times for establishing new models that will use evidence-based care to manage the needs of Americans experiencing serious mental illness and substance use disorders,” McCance-Katz wrote. “SAMHSA will play a key role in establishing these new care approaches and in preparing the behavioral workforce.” ■“McCance-Katz Leads Effort to Focus SAMHSA on Serious Mental Illness” can be accessed here. More information about APA’s grant to expand care for those with serious mental illness is available here. ISSUES NewArchived" @default.
• W2890935450 created "2018-09-27" @default.
• W2890935450 creator A5020158703 @default.
• W2890935450 date "2018-09-21" @default.
• W2890935450 modified "2023-10-18" @default.
• W2890935450 title "SAMHSA Is Taking ‘New Directions,’ Says Agency Leader" @default.
• W2890935450 doi "https://doi.org/10.1176/appi.pn.2018.9b10" @default.
• W2890935450 hasPublicationYear "2018" @default.
• W2890935450 type Work @default.
• W2890935450 sameAs 2890935450 @default.
• W2890935450 citedByCount "0" @default.
• W2890935450 crossrefType "journal-article" @default.
• W2890935450 hasAuthorship W2890935450A5020158703 @default.
• W2890935450 hasConcept C108170787 @default.
• W2890935450 hasConcept C118552586 @default.
• W2890935450 hasConcept C134362201 @default.
• W2890935450 hasConcept C138885662 @default.
• W2890935450 hasConcept C144024400 @default.
• W2890935450 hasConcept C15744967 @default.
• W2890935450 hasConcept C159110408 @default.
• W2890935450 hasConcept C160735492 @default.
• W2890935450 hasConcept C17744445 @default.
• W2890935450 hasConcept C199539241 @default.
• W2890935450 hasConcept C2776674806 @default.
• W2890935450 hasConcept C2778137410 @default.
• W2890935450 hasConcept C36289849 @default.
• W2890935450 hasConcept C40010229 @default.
• W2890935450 hasConcept C41895202 @default.
• W2890935450 hasConcept C48856860 @default.
• W2890935450 hasConcept C71924100 @default.
• W2890935450 hasConceptScore W2890935450C108170787 @default.
• W2890935450 hasConceptScore W2890935450C118552586 @default.
• W2890935450 hasConceptScore W2890935450C134362201 @default.
• W2890935450 hasConceptScore W2890935450C138885662 @default.
• W2890935450 hasConceptScore W2890935450C144024400 @default.
• W2890935450 hasConceptScore W2890935450C15744967 @default.
• W2890935450 hasConceptScore W2890935450C159110408 @default.
• W2890935450 hasConceptScore W2890935450C160735492 @default.
• W2890935450 hasConceptScore W2890935450C17744445 @default.
• W2890935450 hasConceptScore W2890935450C199539241 @default.
• W2890935450 hasConceptScore W2890935450C2776674806 @default.
• W2890935450 hasConceptScore W2890935450C2778137410 @default.
• W2890935450 hasConceptScore W2890935450C36289849 @default.
• W2890935450 hasConceptScore W2890935450C40010229 @default.
• W2890935450 hasConceptScore W2890935450C41895202 @default.
• W2890935450 hasConceptScore W2890935450C48856860 @default.
• W2890935450 hasConceptScore W2890935450C71924100 @default.
• W2890935450 hasIssue "18" @default.
• W2890935450 hasLocation W28909354501 @default.
• W2890935450 hasOpenAccess W2890935450 @default.
• W2890935450 hasPrimaryLocation W28909354501 @default.
• W2890935450 hasRelatedWork W1974512394 @default.
• W2890935450 hasRelatedWork W2031556249 @default.
• W2890935450 hasRelatedWork W2037695402 @default.
• W2890935450 hasRelatedWork W2097688006 @default.
• W2890935450 hasRelatedWork W2147927117 @default.
• W2890935450 hasRelatedWork W2154913456 @default.
• W2890935450 hasRelatedWork W2435230023 @default.
• W2890935450 hasRelatedWork W2892767813 @default.
• W2890935450 hasRelatedWork W3159653452 @default.
• W2890935450 hasRelatedWork W4214832339 @default.
• W2890935450 hasVolume "53" @default.
• W2890935450 isParatext "false" @default.
• W2890935450 isRetracted "false" @default.
• W2890935450 magId "2890935450" @default.
• W2890935450 workType "article" @default.